Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
abbvie
4
×
alzheimer's disease
4
×
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
4
×
life sciences
merck
4
×
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
startups
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
cancer
deals
diagnostics
eli lilly
gilead sciences
glaxosmithkline
novartis
amgen
biogen
What
bio
roundup
drug
acquisitions
biggest
ceo
companies
debut
moves
week
albert
approval
biogen’s
biopharmaceutical
black
bourla
build
buy
company
company’s
continue
convo
crispr
daniel
diamond
diamond’s
dyne’s
earlier
failures
future
gilead
imports
indication
leading
life
littered
maker
mammoth
maps
march
Language
unset
unknown
Current search:
merck
×
abbvie
×
" alzheimer's disease "
×
" indiana top stories "
×
@xconomy.com
4 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com
5 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More